Extensive serum biomarker analysis in patients with macrophage activation syndrome associated with systemic lupus erythematosus

Harry, 2018, Childhood-onset systemic lupus erythematosus: a review and update, J. Pediatr., 196, 22, 10.1016/j.jpeds.2018.01.045 Malattia, 2013, Paediatric-onset systemic lupus erythematosus, Best Pract. Res. Clin. Rheumatol., 27, 351, 10.1016/j.berh.2013.07.007 Grom, 2010, Macrophage activation syndrome: advances towards understanding pathogenesis, Curr. Opin. Rheumatol., 22, 561, 10.1097/01.bor.0000381996.69261.71 Athreya, 2002, Is macrophage activation syndrome a new entity?, Clin. Exp. Rheumatol., 20, 121 Ramanan, 2003, Macrophage activation syndrome-what’s in a name!, J. Rheumatol., 30, 2513 Parodi, 2009, Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients, Arthritis Rheum., 60, 3388, 10.1002/art.24883 Pringe, 2007, Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?, Lupus, 16, 587, 10.1177/0961203307079078 Fukaya, 2008, Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases, Rheumatology, 47, 1686, 10.1093/rheumatology/ken342 Ravelli, 2002, Macrophage activation syndrome, Curr. Opin. Rheumatol., 14, 548, 10.1097/00002281-200209000-00012 Hochberg, 1997, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum., 40, 1725, 10.1002/art.1780400928 Mizuta, 2019, Clinical significance of serum CXCL9 levels as a biomarker for systemic juvenile idiopathic arthritis associated macrophage activation syndrome, Cytokine, 119, 182, 10.1016/j.cyto.2019.03.018 Petty, 2001, International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, J. Rheumatol., 31, 390 Ravelli, 2016, Arthritis Rheum., 68, 566, 10.1002/art.39332 Groom, 2011, CXCR3 ligands: redundant, collaborative and antagonistic functions, Immunol. Cell Biol., 89, 207, 10.1038/icb.2010.158 Zoller, 2011, Hemophagocytosis causes a consumptive anemia of inflammation, J. Exp. Med., 208, 1203, 10.1084/jem.20102538 Tesi, 2015, Hemophagocytic lymphohistiocytosis in 2 patients with underlying IFNgamma receptor deficiency, J. Allergy Clin. Immunol., 135, 1638, 10.1016/j.jaci.2014.11.030 Crayne, 2019, The immunology of macrophage activation syndrome, Front. Immunol., 10, 119, 10.3389/fimmu.2019.00119 Billiau, 2005, Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages, Blood, 105, 1648, 10.1182/blood-2004-08-2997 Bracaglia, 2017, Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophages activation syndrome complicating systemic juvenile idiopathic arthritis, Ann. Rheum. Dis., 76, 166, 10.1136/annrheumdis-2015-209020 Shimizu, 2018, Characteristic elevation of soluble TNF receptor II: I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis, Clin. Exp. Immunol., 191, 349, 10.1111/cei.13026 Jinkawa, 2019, Cytokine profile of macrophage activation syndrome associated with Kawasaki disease, Cytokine, 119, 52, 10.1016/j.cyto.2019.03.001 Shimizu, 2010, Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis, Rheumatology, 49, 1645, 10.1093/rheumatology/keq133 Shimizu, 2015, Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis, Clin. Immunol., 160, 277, 10.1016/j.clim.2015.06.005 Weiss, 2018, Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome, Blood, 131, 1442, 10.1182/blood-2017-12-820852 Girard-Guyonvarc'h, 2018, Unopposed IL-18 signaling leads to severe TLR9-induced macrophage activation syndrome in mice, Blood, 131, 1430, 10.1182/blood-2017-06-789552 Shimizu, 2013, Distinct cytokine profile in juvenile systemic lupus erythematosus-associated macrophage activation syndrome, Clin. Immunol., 146, 73, 10.1016/j.clim.2012.11.004